Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-Ig Replacement in Hypogammaglobulinemic Lung Transplant Recipients
NCT00137748Phase 3Completed
- Sponsor
- Cleveland Clinic
- Start
- Jan 2001
- Primary completion
- Jan 2006
- Modality
- IgG Antibodies, Antibody Conjugates, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human cytomegalovirus immune globulin in hypogammaglobulinemia, sponsored by Cleveland Clinic. Started Jan 2001; status: completed.
02
Drugs
human cytomegalovirus immune globulin
03
Conditions
hypogammaglobulinemia
Beyond the preview
Go deeper on NCT00137748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00137748.